Total Payments
$3,818
2024 Payments
$425.07
Companies
31
Transactions
239
Medicare Patients
5,165
Medicare Billing
$903,163
Payment Breakdown by Category
Food & Beverage$3,697 (96.8%)
Education$120.92 (3.2%)
Other$0.00 (0.0%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $3,697 | 237 | 96.8% |
| Education | $120.92 | 2 | 3.2% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Novo Nordisk Inc | $806.03 | 73 | $0 (2024) |
| SANOFI-AVENTIS U.S. LLC | $434.90 | 25 | $0 (2019) |
| GlaxoSmithKline, LLC. | $254.43 | 13 | $0 (2024) |
| Janssen Pharmaceuticals, Inc | $249.41 | 16 | $0 (2024) |
| ABBVIE INC. | $233.34 | 17 | $0 (2024) |
| PFIZER INC. | $225.71 | 13 | $0 (2024) |
| Amgen Inc. | $221.83 | 7 | $0 (2024) |
| Amarin Pharma Inc. | $188.28 | 15 | $0 (2021) |
| Astellas Pharma US Inc | $184.14 | 6 | $0 (2021) |
| AstraZeneca Pharmaceuticals LP | $105.86 | 7 | $0 (2024) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $425.07 | 21 | ABBVIE INC. ($69.64) |
| 2023 | $556.35 | 36 | AbbVie Inc. ($163.70) |
| 2022 | $94.99 | 6 | Novartis Pharmaceuticals Corporation ($28.80) |
| 2021 | $417.68 | 21 | Astellas Pharma US Inc ($127.65) |
| 2020 | $195.64 | 11 | GlaxoSmithKline, LLC. ($74.87) |
| 2019 | $670.68 | 38 | Novo Nordisk Inc ($275.50) |
| 2018 | $773.34 | 50 | SANOFI-AVENTIS U.S. LLC ($165.50) |
| 2017 | $683.89 | 56 | SANOFI-AVENTIS U.S. LLC ($149.90) |
All Payment Transactions
239 individual payment records from CMS Open Payments — Page 1 of 10
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 11/19/2024 | Cook Medical LLC | ZILVER PTX (Device) | Food and Beverage | Cash or cash equivalent | $15.65 | General |
| Category: Peripheral Intervention | ||||||
| 09/25/2024 | AstraZeneca Pharmaceuticals LP | FARXIGA (Drug) | Food and Beverage | In-kind items and services | $21.23 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 09/20/2024 | GlaxoSmithKline, LLC. | TRELEGY ELLIPTA (Drug), AREXVY | Food and Beverage | In-kind items and services | $18.11 | General |
| Category: RESPIRATORY | ||||||
| 09/19/2024 | Philips North America LLC | (8874) inCourage (Device) | Food and Beverage | Cash or cash equivalent | $14.46 | General |
| Category: Medical Device | ||||||
| 09/12/2024 | Janssen Pharmaceuticals, Inc | XARELTO (Drug) | Food and Beverage | In-kind items and services | $18.96 | General |
| Category: Cardiovascular & Metabolism | ||||||
| 08/22/2024 | ABBVIE INC. | UBRELVY (Drug) | Food and Beverage | In-kind items and services | $34.22 | General |
| Category: NEUROSCIENCE | ||||||
| 08/12/2024 | Sumitomo Pharma America, Inc. | GEMTESA (Drug) | Food and Beverage | In-kind items and services | $14.27 | General |
| Category: UROLOGY | ||||||
| 08/08/2024 | AstraZeneca Pharmaceuticals LP | BREZTRI (Drug) | Food and Beverage | In-kind items and services | $18.04 | General |
| Category: Respiratory | ||||||
| 07/24/2024 | Medtronic, Inc. | MINIMED 780G (Device) | Food and Beverage | In-kind items and services | $19.39 | General |
| Category: Durable Pump | ||||||
| 07/10/2024 | Boehringer Ingelheim Pharmaceuticals, Inc. | TRADJENTA (Drug), JARDIANCE | Food and Beverage | In-kind items and services | $21.73 | General |
| Category: DIABETES | ||||||
| 06/05/2024 | Xeris Pharmaceuticals, Inc. | GVOKE HYPOPEN (Drug) | Food and Beverage | In-kind items and services | $20.91 | General |
| Category: Diabetes | ||||||
| 05/29/2024 | Bayer Healthcare Pharmaceuticals Inc. | Kerendia (Drug) | Food and Beverage | In-kind items and services | $21.39 | General |
| Category: Cardio-renal | ||||||
| 05/23/2024 | Novo Nordisk Inc | Wegovy (Drug) | Food and Beverage | In-kind items and services | $21.76 | General |
| Category: Obesity | ||||||
| 05/20/2024 | ABBVIE INC. | QULIPTA (Drug), UBRELVY | Food and Beverage | In-kind items and services | $13.23 | General |
| Category: NEUROSCIENCE | ||||||
| 05/16/2024 | Lilly USA, LLC | JARDIANCE (Drug) | Food and Beverage | In-kind items and services | $29.64 | General |
| Category: Diabetes | ||||||
| 05/08/2024 | PFIZER INC. | PREVNAR 20 (Biological), COMIRNATY, ABRYSVO | Food and Beverage | In-kind items and services | $26.79 | General |
| Category: VACCINES | ||||||
| 05/07/2024 | Amgen Inc. | Otezla (Drug), Repatha | Food and Beverage | In-kind items and services | $16.67 | General |
| Category: Inflammation | ||||||
| 04/24/2024 | Philips North America LLC | (8874) inCourage (Device) | Food and Beverage | Cash or cash equivalent | $18.97 | General |
| Category: Medical Device | ||||||
| 02/21/2024 | Novo Nordisk Inc | Rybelsus (Drug), Ozempic | Food and Beverage | In-kind items and services | $17.59 | General |
| Category: Diabetes | ||||||
| 02/14/2024 | Boehringer Ingelheim Pharmaceuticals, Inc. | TRADJENTA (Drug), JARDIANCE | Food and Beverage | In-kind items and services | $19.87 | General |
| Category: DIABETES | ||||||
| 02/05/2024 | ABBVIE INC. | UBRELVY (Drug) | Food and Beverage | In-kind items and services | $22.19 | General |
| Category: NEUROSCIENCE | ||||||
| 12/15/2023 | Novo Nordisk Inc | Ozempic (Drug), Rybelsus | Food and Beverage | In-kind items and services | $9.85 | General |
| Category: Diabetes | ||||||
| 11/11/2023 | AbbVie Inc. | QULIPTA (Drug), UBRELVY | Food and Beverage | In-kind items and services | $23.03 | General |
| Category: NEUROSCIENCE | ||||||
| 10/10/2023 | AbbVie Inc. | QULIPTA (Drug), UBRELVY | Food and Beverage | In-kind items and services | $22.74 | General |
| Category: NEUROSCIENCE | ||||||
| 09/20/2023 | Sumitomo Pharma America, Inc. | GEMTESA (Drug) | Food and Beverage | In-kind items and services | $7.59 | General |
| Category: UROLOGY | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 22 | 1,351 | 2,834 | $487,295 | $235,160 |
| 2022 | 23 | 1,450 | 3,021 | $498,212 | $246,213 |
| 2021 | 15 | 1,003 | 2,368 | $385,013 | $198,999 |
| 2020 | 18 | 1,361 | 3,136 | $465,748 | $222,791 |
Total Patients
5,165
Total Services
11,359
Medicare Billing
$903,163
Procedure Codes
78
All Medicare Procedures & Services
78 procedure records from CMS Medicare Utilization — Page 1 of 4
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 330 | 1,119 | $228,869 | $99,873 | 43.6% |
| 99309 | Subsequent nursing facility care with moderate level of medical decision making, per day, if using time, at least 30 minutes | Facility | 2023 | 19 | 337 | $48,360 | $29,070 | 60.1% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 195 | 442 | $66,300 | $28,020 | 42.3% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2023 | 193 | 193 | $40,244 | $25,723 | 63.9% |
| 90694 | Influenza vaccine, quadrivalent inactivated, 0.5 ml dosage | Office | 2023 | 128 | 131 | $20,173 | $9,887 | 49.0% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2023 | 50 | 58 | $16,543 | $8,177 | 49.4% |
| 99310 | Subsequent nursing facility care with high level of medical decision making, per day, if using time, at least 45 minutes | Facility | 2023 | 11 | 55 | $11,660 | $6,484 | 55.6% |
| 99306 | Initial nursing facility care with high level of medical decision making, per day, if using time, at least 45 minutes | Facility | 2023 | 19 | 33 | $8,447 | $4,881 | 57.8% |
| G0008 | Administration of influenza virus vaccine | Office | 2023 | 140 | 143 | $7,150 | $4,556 | 63.7% |
| 90677 | Pneumococcal conjugate vaccine, 20 valent (pcv20), for intramuscular use | Office | 2023 | 15 | 15 | $5,100 | $4,229 | 82.9% |
| 99497 | Advance care planning, first 30 minutes | Office | 2023 | 52 | 53 | $9,273 | $3,098 | 33.4% |
| G0438 | Annual wellness visit; includes a personalized prevention plan of service (pps), initial visit | Office | 2023 | 17 | 17 | $4,485 | $2,890 | 64.4% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2023 | 24 | 24 | $6,342 | $2,373 | 37.4% |
| G0179 | Physician or allowed practitioner re-certification for medicare-covered home health services under a home health plan of care (patient not present), including contacts with home health agency and review of reports of patient status required by physicians a | Office | 2023 | 11 | 40 | $2,604 | $1,342 | 51.5% |
| 99212 | Established patient office or other outpatient visit, 10-19 minutes | Office | 2023 | 11 | 24 | $1,800 | $1,089 | 60.5% |
| 99203 | New patient office or other outpatient visit, 30-44 minutes | Office | 2023 | 12 | 12 | $2,127 | $830.70 | 39.1% |
| G0180 | Physician or allowed practitioner certification for medicare-covered home health services under a home health plan of care (patient not present), including contacts with home health agency and review of reports of patient status required by physicians and | Office | 2023 | 17 | 19 | $2,660 | $778.32 | 29.3% |
| G0009 | Administration of pneumococcal vaccine | Office | 2023 | 19 | 19 | $950.00 | $605.34 | 63.7% |
| 90674 | Influenza vaccine, quadrivalent derived from cell cultures, preservative and antibiotic free | Office | 2023 | 17 | 17 | $1,190 | $567.47 | 47.7% |
| 93000 | Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report | Office | 2023 | 30 | 30 | $1,350 | $323.46 | 24.0% |
| 96372 | Injection of drug or substance under skin or into muscle | Office | 2023 | 17 | 22 | $892.32 | $258.28 | 28.9% |
| 81002 | Urinalysis, manual test | Office | 2023 | 24 | 31 | $775.00 | $105.71 | 13.6% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 305 | 1,029 | $210,461 | $96,607 | 45.9% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 235 | 677 | $101,550 | $45,719 | 45.0% |
| 99309 | Follow-up nursing facility visit per day, typically 25 minutes | Facility | 2022 | 36 | 331 | $47,499 | $24,210 | 51.0% |
About Dr. Javed Ahmad, MD
Dr. Javed Ahmad, MD is a Internal Medicine healthcare provider based in Indio, California. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 08/18/2006. The National Provider Identifier (NPI) number assigned to this provider is 1346354479.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Javed Ahmad, MD has received a total of $3,818 in payments from pharmaceutical and medical device companies, with $425.07 received in 2024. These payments were reported across 239 transactions from 31 companies. The most common payment nature is "Food and Beverage" ($3,697).
As a Medicare-enrolled provider, Ahmad has provided services to 5,165 Medicare beneficiaries, totaling 11,359 services with total Medicare billing of $903,163. Data is available for 4 years (2020–2023), covering 78 distinct procedure/service records.
Ad
Practice Information
- Specialty Internal Medicine
- Location Indio, CA
- Active Since 08/18/2006
- Last Updated 06/10/2011
- Taxonomy Code 207R00000X
- Entity Type Individual
- Practice Solo Practitioner
- NPI Number 1346354479
Products in Payments
- Saxenda (Drug) $254.37
- XARELTO (Drug) $234.07
- Ozempic (Drug) $215.67
- Vascepa (Drug) $188.28
- SOLIQUA (Drug) $179.97
- TOUJEO (Drug) $164.61
- UBRELVY (Drug) $153.39
- Victoza (Drug) $134.50
- Prolia (Biological) $117.86
- GEMTESA (Drug) $103.75
- ENTRESTO (Drug) $101.28
- SHINGRIX (Biological) $97.92
- Tresiba (Drug) $97.51
- SOLIQUA 100/33 (Drug) $90.32
- MYRBETRIQ (Drug) $68.76
- Rybelsus (Drug) $68.40
- Livalo (Drug) $67.62
- Otezla (Drug) $67.38
- FARXIGA (Drug) $62.74
- QULIPTA (Drug) $59.00
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Internal Medicine Doctors in Indio
Mr. Assad Darawal, Md, MD
Internal Medicine — Payments: $12,134
Internal Medicine $12,134
Dr. Naeem Rana, M.d, M.D
Internal Medicine — Payments: $1,315
Internal Medicine $1,315
Dr. Gregory Kuldanek, M.d, M.D
Internal Medicine — Payments: $1,276
Internal Medicine $1,276
Mr. Mustaqeem Qazi, Md, MD
Internal Medicine — Payments: $1,176
Internal Medicine $1,176
Saeed Eskandari, M.d, M.D
Internal Medicine — Payments: $203.21
Internal Medicine $203.21
Dr. Kishor Vachhani, Md, MD
Internal Medicine — Payments: $81.80
Internal Medicine $81.80